COVID-19: The Hidden Impact on Mental Health and Drug Addiction

Chiappini, Stefania; Guirguis, Amira; John, Ann; Corkery, John; Schifano, Fabrizio

doi:10.3389/fpsyt.2020.00767

Cited by 126 publications

(109 citation statements)

References 32 publications

Supporting

Mentioning

106

Contrasting

Unclassified

Order By: Relevance

“…Fear, stress, and anxiety have affected people all over the world, exacerbating latent psychiatric and psychological disorders (14). Furthermore, the general feeling of uncertainty is fueled by the probable economic crisis that will result from the disruption of non-essential businesses in most countries (15). Fragile categories such as people with drug use disorder suffer from the life-style changes, posing additional public health concerns (16).…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Consequences of COVID-19 Lockdown on the Misuse and Marketing of Addictive Substances and New Psychoactive Substances

Trana¹,

Carlier

Berretta

et al. 2020

Front. Psychiatry

View full text Add to dashboard Cite

Section: Discussionmentioning

confidence: 99%

“…As suggested by Zaami et al, the continuation of drug treatment services along with the implementation of psychiatric and psychological assistance to people with drug use disorder should be ensured to reduce harm (16). To date, a constructive international network is continuously working to monitor the drug market (15,16).…”

Section: Discussionmentioning

confidence: 99%

Consequences of COVID-19 Lockdown on the Misuse and Marketing of Addictive Substances and New Psychoactive Substances

Trana¹,

Carlier

Berretta

et al. 2020

Front. Psychiatry

View full text Add to dashboard Cite

“…mood and anxiety disorders, psychoses, etc. ; homelessness, incarceration, economic difficulties, and other socioeconomic issues deriving from drug addiction [133][134][135][136][137][138]. Moreover, the COVID-19 pandemic is impacting drug markets, there have been reports of supply shortages of numerous drugs, e.g.…”

Section: Abuse Of Drugs During the Covid-19 Pandemicmentioning

confidence: 99%

“…Moreover, the COVID-19 pandemic is impacting drug markets, there have been reports of supply shortages of numerous drugs, e.g. opioids, at the street level, as well as price increases for consumers on the black market and reductions in purity [133][134]139]. These issues, in combination with a general economic loss, can encourage shifts to more risky drug using behaviours (such as the use of domestically produced substances); use of prescription/OTC drugs; or mixing with cheaper drugs (such as 'street benzos') and synthetic cannabinoids [139].…”

Section: Abuse Of Drugs During the Covid-19 Pandemicmentioning

confidence: 99%

Misuse of prescription and over-the-counter drugs to obtain illicit highs: how pharmacists can prevent abuse

Chiappini¹,

Guirguis²,

Corkery³

et al. 2020

The Pharmaceutical Journal

View full text Add to dashboard Cite

There have been increasing reports of misuse of a range of prescription and over-the-counter (OTC) drugs for recreational purposes. The use of psychoactive pharmaceuticals and 'pharming' are new, widespread phenomena involving the non-medical use of prescription and OTC drugs, which are recreationally used to achieve psychoactive effects either on their own or in combination with other substances. This article provides an overview of the topic, focusing on a range of medicines (e.g. prescription medicines such as quetiapine, gabapentinoids, Z-drugs, bupropion, venlafaxine, and over-thecounter medicines such as loperamide, dextromethorphan, benzydamine, promethazine, chlorphenamine, diphenhydramine and hyoscine butylbromide) that have emerged as misused and diverted, or already described through the literature, as well as recorded by drug users' online websites reporting new trends and experimentations of drug abuse. This rapidly changing drug scenario represents a challenge for pharmacy, psychiatry, public health and drug control policies. Moreover, possibly resulting from the COVID-19 pandemic, drug use-habits and availability have changed, causing a shift in behaviours relating to both prescription and OTC medicines. Healthcare professionals should be aware of potential prescription drugs diversion, recognise misuse cases, consider the possibility of polydrug misuse, and prevent it where possible. Pharmacists can play a key role in preventing and reducing drug abuse and should be involved in evidence-based actions to detect, understand and prevent drug diversion activities and the adverse effects of drug-misuse.

show abstract

“…The military has significant support systems for individuals who have or may develop PTSD (Miao, Chen, Wei, Tao, & Lu, 2018). The impact of PTSD in civilian nurses caring for COVID‐19 patients is expected to be as significant, if not more so, as it has been for military nurses (Chiappini et al., 2020). There is an ethical and moral obligation to provide for the mental health needs of the nurses caring for COVID‐19 patients (Menon & Padhy, 2020).…”

Section: Post‐traumatic Stress Disorder (Ptsd)mentioning

confidence: 99%

What can we learn from U.S. military nursing and COVID‐19?

Anders

2020

Nursing Inquiry

View full text Add to dashboard Cite

The devastation of the COVID-19 pandemic to citizens of China, Italy, Brazil, and the United States, as well as other parts of the world, has been overwhelming (Borghese & Braithwaite, 2020). With reported deaths over 865,000 worldwide, the virus has stretched the capability of the global healthcare system to respond (World Health Association [WHO], 2020). Among those at risk of dying are the healthcare professionals caring for victims of the pandemic. The number of deaths of nurses and physicians grows each day (In Memoriam, August 30, 2020). In many instances, these seem to have been needless deaths because of our failed public policy regarding the management of the COVID-19 pandemic (Why wasn't, 2020). Most nurses would not have anticipated being exposed daily to life-threatening situations in modern healthcare settings. 1 How to cite this article: Anders RL. What can we learn from

show abstract

COVID-19: The Hidden Impact on Mental Health and Drug Addiction

Cited by 126 publications

References 32 publications

Consequences of COVID-19 Lockdown on the Misuse and Marketing of Addictive Substances and New Psychoactive Substances

Consequences of COVID-19 Lockdown on the Misuse and Marketing of Addictive Substances and New Psychoactive Substances

Misuse of prescription and over-the-counter drugs to obtain illicit highs: how pharmacists can prevent abuse

What can we learn from U.S. military nursing and COVID‐19?

Contact Info

Product

Resources

About